Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

DCPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.43%

Insider Buying (Last 12 Months): $30,291,248.00

Insider Selling (Last 12 Months): $310,778.43

Deciphera Pharmaceuticals Insider Trading History Chart

Deciphera Pharmaceuticals Share Price & Price History

^$12.72

▼ -0.02 (-0.16%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Top Analyst Exposes Imminent Crisis Hurtling Towards America

From Porter and Company | Ad

The man who warned of the dot-com blow up, the 2008 housing collapse, and the loss of America’s AAA rating makes a shocking prediction…

Watch the most eye-opening film of the year for free

Deciphera Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2023	Jama Pitman	Insider	Sell	1,238	$14.40	$17,827.20	43,812
6/16/2023	Matthew L. Sherman	EVP	Sell	1,655	$14.40	$23,832.00	87,686
6/8/2023	Franklin Stuart Friedman	Director	Buy	10,000	$13.88	$138,800.00	10,000
5/10/2023	Dennis Leo Walsh	Director	Buy	11,000	$13.86	$152,460.00	11,000
3/21/2023	Steven L. Hoerter	CEO	Sell	7,500	$15.57	$116,775.00
2/16/2023	Daniel C Martin	Insider	Sell	1,159	$15.10	$17,500.90	58,381
2/16/2023	Matthew L. Sherman	EVP	Sell	971	$15.10	$14,662.10	88,145
2/16/2023	Thomas Patrick Kelly	CFO	Sell	1,370	$15.10	$20,687.00	58,795
1/24/2023	Brightstar Associates Llc	Major Shareholder	Buy	1,666,666	$18.00	$29,999,988.00	19,718,014
1/17/2023	Daniel Lee Flynn	Insider	Sell	2,403	$21.24	$51,039.72	43,695
10/3/2022	Matthew L. Sherman	EVP	Sell	2,587	$18.73	$48,454.51	74,297
6/16/2022	Jama Pitman	Insider	Sell	1,298	$10.75	$13,953.50	36,661
6/16/2022	Matthew L. Sherman	EVP	Sell	1,768	$10.75	$19,006.00	76,884
4/29/2022	Brightstar Associates Llc	Major Shareholder	Buy	1,478,978	$10.00	$14,789,780.00	18,051,348
2/16/2022	Daniel Lee Flynn	Insider	Sell	1,366	$9.05	$12,362.30
2/16/2022	Matthew L. Sherman	EVP	Sell	984	$9.05	$8,905.20
2/16/2022	Thomas Patrick Kelly	CFO	Sell	1,368	$9.05	$12,380.40
10/4/2021	Matthew L. Sherman	EVP	Sell	2,659	$33.17	$88,199.03
4/19/2021	James Arthur Bristol	Director	Sell	5,300	$46.26	$245,178.00	5,300
4/12/2021	James Arthur Bristol	Director	Sell	14,700	$43.84	$644,448.00	14,700
4/1/2021	Michael Douglas Taylor	Director	Sell	8,000	$45.57	$364,560.00	8,000
1/4/2021	Michael Douglas Taylor	Director	Sell	19,000	$56.45	$1,072,550.00	19,000
12/1/2020	Michael Douglas Taylor	Director	Sell	19,000	$60.90	$1,157,100.00	19,000

New Options Traders Now Have A Unique Advantage

From Tradewins | Ad

Options expert and 10x trading champion Chuck Hughes still remembers what it was like to begin trading with no experience.

I was a pilot - I read books on trading on layovers. Now I’m here and these strategies are a big reason…

In his free guide, "How To Trade Options", Hughes explains how to make the most of options trading, even when you have no experience!

Click here to continue reading…

SEC Filings (Institutional Ownership Changes) for Deciphera Pharmaceuticals (NASDAQ:DCPH)

70.96% of Deciphera Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Deciphera Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/22/2023	Virginia Retirement Systems ET AL	75,000	$1.06M	0.0%	N/A	0.095%
8/21/2023	California State Teachers Retirement System	60,550	$0.85M	0.0%	-7.0%	0.077%
8/16/2023	Nuveen Asset Management LLC	1,354,565	$19.07M	0.0%	+2.5%	1.719%
8/15/2023	Wells Fargo & Company MN	59,603	$0.84M	0.0%	+23.2%	0.076%
8/15/2023	Dana Investment Advisors Inc.	35,316	$0.50M	0.0%	+2.5%	0.045%
8/15/2023	Goldman Sachs Group Inc.	2,124,034	$29.91M	0.0%	-30.5%	2.695%
8/15/2023	Point72 Asset Management L.P.	618,946	$8.72M	0.0%	+737.0%	0.785%
8/15/2023	Royal Bank of Canada	8,095	$0.11M	0.0%	+29.1%	0.010%
8/15/2023	Braidwell LP	3,646,419	$51.34M	1.7%	+12.5%	4.626%
8/14/2023	Ergoteles LLC	16,309	$0.23M	0.0%	N/A	0.021%
8/14/2023	Tower Research Capital LLC TRC	6,817	$96K	0.0%	+144.1%	0.009%
8/14/2023	Schonfeld Strategic Advisors LLC	226,953	$3.20M	0.0%	-8.2%	0.288%
8/14/2023	State of Wisconsin Investment Board	45,456	$0.64M	0.0%	-16.7%	0.058%
8/14/2023	State Street Corp	3,169,495	$44.63M	0.0%	-4.6%	4.021%
8/14/2023	Jefferies Financial Group Inc.	430,268	$6.06M	0.1%	-63.4%	0.546%
8/14/2023	Nuveen Asset Management LLC	1,354,565	$19.07M	0.0%	+2.5%	1.719%
8/14/2023	Thrivent Financial for Lutherans	139,809	$1.97M	0.0%	-4.7%	0.177%
8/14/2023	Graham Capital Management L.P.	15,448	$0.22M	0.0%	N/A	0.020%
8/11/2023	Renaissance Technologies LLC	120,600	$1.70M	0.0%	-47.9%	0.154%
8/11/2023	Credit Suisse AG	61,717	$0.87M	0.0%	+26.6%	0.079%
8/11/2023	BlackRock Inc.	5,467,999	$76.99M	0.0%	-1.4%	6.963%
8/11/2023	State Board of Administration of Florida Retirement System	14,870	$0.21M	0.0%	-10.5%	0.019%
8/11/2023	The Manufacturers Life Insurance Company	21,778	$0.31M	0.0%	-65.3%	0.028%
8/11/2023	Hsbc Holdings PLC	137,610	$1.94M	0.0%	N/A	0.175%
8/11/2023	Trexquant Investment LP	36,402	$0.51M	0.0%	-39.8%	0.046%
8/11/2023	Geode Capital Management LLC	1,109,405	$15.62M	0.0%	+4.1%	1.413%
8/11/2023	E Fund Management Co. Ltd.	12,429	$0.18M	0.0%	-6.5%	0.016%
8/11/2023	JPMorgan Chase & Co.	80,354	$1.13M	0.0%	+17.4%	0.102%
8/11/2023	Northern Trust Corp	517,765	$7.29M	0.0%	+2.4%	0.659%
8/11/2023	ExodusPoint Capital Management LP	540,316	$7.61M	0.1%	+24.3%	0.688%
8/10/2023	Profund Advisors LLC	42,085	$0.59M	0.0%	-3.4%	0.054%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	42,127	$0.59M	0.0%	+23.7%	0.054%
8/10/2023	Jupiter Asset Management Ltd.	44,139	$0.62M	0.0%	N/A	0.056%
8/10/2023	US Bancorp DE	3,424	$48K	0.0%	-20.7%	0.004%
8/10/2023	Charles Schwab Investment Management Inc.	493,260	$6.95M	0.0%	+8.0%	0.628%
8/10/2023	Citigroup Inc.	86,523	$1.22M	0.0%	-54.9%	0.110%
8/9/2023	Dimensional Fund Advisors LP	1,408,514	$19.83M	0.0%	+2.7%	1.794%
8/9/2023	BNP Paribas Arbitrage SNC	50,841	$0.72M	0.0%	-65.5%	0.065%
8/9/2023	Swiss National Bank	106,700	$1.50M	0.0%	-5.3%	0.136%
8/8/2023	Rhumbline Advisers	80,336	$1.13M	0.0%	+4.0%	0.102%
8/8/2023	AlphaCentric Advisors LLC	77,500	$1.09M	0.6%	+6.9%	0.099%
8/7/2023	Principal Financial Group Inc.	16,567	$0.23M	0.0%	+6.3%	0.021%
8/7/2023	New York Life Investment Management LLC	26,675	$0.38M	0.0%	-12.8%	0.034%
8/4/2023	Cibc World Markets Corp	300,000	$4.22M	0.0%	N/A	0.382%
8/3/2023	Los Angeles Capital Management LLC	13,435	$0.19M	0.0%	-25.8%	0.017%
8/3/2023	Barclays PLC	141,595	$1.99M	0.0%	+12.8%	0.180%
8/3/2023	Bank of New York Mellon Corp	204,875	$2.89M	0.0%	+7.9%	0.261%
8/2/2023	Bank of Montreal Can	92,060	$1.33M	0.0%	N/A	0.117%
8/1/2023	Arizona State Retirement System	13,769	$0.19M	0.0%	-9.0%	0.018%
7/31/2023	Inspire Investing LLC	24,949	$0.35M	0.0%	+24.9%	0.032%
7/24/2023	Allspring Global Investments Holdings LLC	138,431	$1.95M	0.0%	-6.1%	0.176%
7/20/2023	Exchange Traded Concepts LLC	9,803	$0.14M	0.0%	N/A	0.012%
7/19/2023	Teacher Retirement System of Texas	13,310	$0.19M	0.0%	-17.2%	0.017%
7/18/2023	Allspring Global Investments Holdings LLC	138,431	$1.95M	0.0%	-6.1%	0.176%
7/10/2023	SG Americas Securities LLC	152,974	$2.15M	0.0%	+815.1%	0.195%
5/22/2023	Ameriprise Financial Inc.	114,850	$1.77M	0.0%	-4.8%	0.146%
5/18/2023	JPMorgan Chase & Co.	68,445	$1.06M	0.0%	-7.5%	0.087%
5/18/2023	New York State Common Retirement Fund	24,205	$0.37M	0.0%	-25.7%	0.031%
5/16/2023	Jane Street Group LLC	54,853	$0.85M	0.0%	+13.5%	0.070%
5/16/2023	State Street Corp	3,322,150	$51.33M	0.0%	-3.7%	4.231%
5/16/2023	Squarepoint Ops LLC	154,605	$2.39M	0.0%	+112.5%	0.197%
5/16/2023	Geode Capital Management LLC	1,066,104	$16.47M	0.0%	+17.0%	1.358%
5/16/2023	AQR Capital Management LLC	31,350	$0.48M	0.0%	N/A	0.040%
5/16/2023	Armistice Capital LLC	4,100,000	$63.35M	0.9%	-20.7%	5.221%
5/16/2023	Alberta Investment Management Corp	37,791	$0.58M	0.0%	+84.9%	0.048%
5/16/2023	Alyeska Investment Group L.P.	20,400	$0.32M	0.0%	N/A	0.026%
5/15/2023	Schonfeld Strategic Advisors LLC	247,238	$3.82M	0.0%	+27.6%	0.315%
5/15/2023	Cubist Systematic Strategies LLC	123,486	$1.91M	0.0%	-8.6%	0.157%
5/15/2023	Braidwell LP	3,241,351	$50.08M	1.7%	-0.9%	4.128%
5/15/2023	Public Employees Retirement System of Ohio	29,130	$0.45M	0.0%	-47.4%	0.037%
5/15/2023	Bayesian Capital Management LP	22,411	$0.35M	0.0%	N/A	0.029%
5/15/2023	Two Sigma Advisers LP	475,700	$7.35M	0.0%	+13.4%	0.606%
5/15/2023	Two Sigma Investments LP	178,706	$2.76M	0.0%	-50.2%	0.228%
5/15/2023	Deutsche Bank AG	180,272	$2.79M	0.0%	+729.7%	0.230%
5/15/2023	Price T Rowe Associates Inc. MD	599,675	$9.27M	0.0%	-4.0%	0.764%
5/15/2023	Boothbay Fund Management LLC	30,236	$0.47M	0.0%	-54.9%	0.039%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	84,000	$1.30M	0.0%	-4.5%	0.107%
5/12/2023	Renaissance Technologies LLC	231,318	$3.57M	0.0%	+155.0%	0.295%
5/12/2023	BlackRock Inc.	5,544,988	$85.67M	0.0%	+2.3%	7.061%
5/12/2023	BNP Paribas Arbitrage SNC	147,363	$2.28M	0.0%	+46.4%	0.188%
5/12/2023	AlphaCentric Advisors LLC	72,500	$1.12M	0.8%	N/A	0.092%
5/12/2023	Bank of America Corp DE	333,873	$5.16M	0.0%	+17.5%	0.425%
5/12/2023	UBS Group AG	95,396	$1.47M	0.0%	-43.7%	0.121%
5/12/2023	Dimensional Fund Advisors LP	1,371,796	$21.19M	0.0%	+27.4%	1.747%
5/12/2023	Wellington Management Group LLP	79,289	$1.23M	0.0%	-30.5%	0.101%
5/12/2023	Charles Schwab Investment Management Inc.	456,645	$7.06M	0.0%	+26.9%	0.582%
5/12/2023	Profund Advisors LLC	43,547	$0.67M	0.0%	N/A	0.055%
5/11/2023	FMR LLC	68,595	$1.06M	0.0%	-13.3%	0.087%
5/11/2023	ExodusPoint Capital Management LP	434,670	$6.72M	0.1%	-25.0%	0.554%
5/11/2023	American Century Companies Inc.	15,215	$0.23M	0.0%	+27.5%	0.019%
5/11/2023	Envestnet Asset Management Inc.	12,629	$0.20M	0.0%	N/A	0.016%
5/11/2023	Rhumbline Advisers	77,256	$1.19M	0.0%	+14.6%	0.098%
5/11/2023	Citigroup Inc.	191,804	$2.96M	0.0%	+70.6%	0.244%
5/10/2023	Ameritas Investment Partners Inc.	4,149	$64K	0.0%	+25.5%	0.005%
5/10/2023	Credit Suisse AG	48,763	$0.75M	0.0%	+36.5%	0.062%
5/10/2023	Swiss National Bank	112,700	$1.74M	0.0%	+16.4%	0.144%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	15,887	$0.25M	0.0%	N/A	0.020%
5/9/2023	Principal Financial Group Inc.	15,584	$0.24M	0.0%	+11.0%	0.020%
5/9/2023	Tower Research Capital LLC TRC	2,793	$43K	0.0%	-78.4%	0.004%
5/9/2023	Bank of New York Mellon Corp	189,824	$2.93M	0.0%	+8.2%	0.242%

Data available starting January 2016

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $12.72

$12.55

$12.85

50 Day Range

MA: $13.82

$12.46

$15.48

52 Week Range

Now: $12.72

$12.33

$22.76

Volume

281,976 shs

Average Volume

399,609 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Deciphera Pharmaceuticals?: Deciphera Pharmaceuticals' top insider investors include:
Brightstar Associates Llc (Major Shareholder)
Matthew L Sherman (EVP)
Thomas Patrick Kelly (CFO)
Daniel C Martin (Insider)
Jama Pitman (Insider)
Daniel Lee Flynn (Insider)
Dennis Leo Walsh (Director)
Franklin Stuart Friedman (Director)
Steven L Hoerter (CEO)
Learn More about top insider investors at Deciphera Pharmaceuticals.